Improve study quality, accelerate decision making and reduce site and sponsor burden by harnessing the power of IQVIA’s integrated Interactive Response Technology (IRT) and electronic Clinical Outcome Assessment (eCOA) solution.
Implementing clinical technology strategies that improve data quality, reduce site effort, and optimize workflows is more important than ever. In addition, with the sharp rise in investigational product (IP) and shipping costs, it is crucial to take an integrated platform approach including advanced drug supply tools that optimize trial supply and support sustainability goals.
When sponsors invest in best of breed solutions that leverage intelligent integration and workflow automation, it is possible to support both a positive technology experience for sites as well as the optimization of the clinical supply chain.
In this webinar, IQVIA experts will share how to utilize integration and automation strategies to maximize trial efficiencies, reduce costs, and align with sustainability goals.
Improve study quality, accelerate decision making and reduce site and sponsor burden by harnessing the power of IQVIA’s integrated Interactive Response Technology (IRT) and electronic Clinical Outcome Assessment (eCOA) solution.
Power your decentralized trial with an agile randomization and trial supply management solution that supports supply flexibility and optimization as well as adaptable direct to patient options.
Deliver eConsent to sites and study participants around the globe with confidence
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.